These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 3410595)
1. Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertension. Madonna O; Labeeuw M; Pozet N; Aissa AH; Zech P Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):133-7. PubMed ID: 3410595 [TBL] [Abstract][Full Text] [Related]
2. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]
3. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension. Reams GP; Bauer JH; Lau A J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665 [TBL] [Abstract][Full Text] [Related]
4. Effect of oral penbutolol on renal haemodynamics of hypertensive patients with renal insufficiency. Bailey RR; Carlson RV; Walker RJ; Swainson CP N Z Med J; 1985 Aug; 98(785):683-5. PubMed ID: 3863029 [TBL] [Abstract][Full Text] [Related]
6. [Changes in hemodynamics and renal function during the oral administration of betaxolol]. Pathe M; Schwartz J Therapie; 1985; 40(4):209-12. PubMed ID: 2862715 [No Abstract] [Full Text] [Related]
7. Metoprolol in high renin hypertension. A comparison with propranolol. Lameyer LD; Hesse CJ Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889 [TBL] [Abstract][Full Text] [Related]
8. A comparison of betaxolol and nadolol on renal function in essential hypertension. Bauer JH; Reams GP; Lau A Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292 [TBL] [Abstract][Full Text] [Related]
9. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function. Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633 [TBL] [Abstract][Full Text] [Related]
10. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease. Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161 [TBL] [Abstract][Full Text] [Related]
11. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function]. Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693 [TBL] [Abstract][Full Text] [Related]
12. [Captopril in the treatment of arterial hypertension in chronic nephritis]. Kutyrina IM; Rogov VA; Lifshits NL; Klepikov PV Ter Arkh; 1986; 58(8):92-6. PubMed ID: 3532416 [TBL] [Abstract][Full Text] [Related]
13. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system. Walker LA; Gellai M; Valtin H J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818 [TBL] [Abstract][Full Text] [Related]
14. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate. Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461 [TBL] [Abstract][Full Text] [Related]
15. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. Demeilliers B; Jover B; Mimran A J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648 [TBL] [Abstract][Full Text] [Related]
16. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related]
17. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists? Bauer JH; Reams GP J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071 [TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension. Rasmussen S; Ibsen H; Giese J Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study. Imai Y; Abe K; Sato M; Kasai Y; Sato K; Omata K; Sasaki S; Nihei M; Sekino H; Yoshinaga K Arzneimittelforschung; 1986 May; 36(5):869-73. PubMed ID: 3730023 [TBL] [Abstract][Full Text] [Related]